How do you pitch Sofinnova Investments?

The most effective path to Sofinnova Investments is a warm introduction from a founder in their portfolio or a trusted co-investor. Use AngelSearch Signal to map your intro paths.

What is Sofinnova Investments's typical check size?

Sofinnova Investments typically writes checks between $1B and $25B.

What industries does Sofinnova Investments focus on?

Sofinnova Investments invests in Biotech, Healthcare, Venture Capital.

Sofinnova Investments

Venture CapitalActive

Sofinnova Investments specializes in seed, startup, mid, early stage, series A, first venture round, and corporate spinouts.

Menlo Park, United StatesFounded 2008sofinnova.com

224

Investments

Exits

$2.5B

AUM

4.5%

Exit Rate

Get contact info, warm intros & fit scores

Get started free

Investment Thesis & Strategy

Sofinnova Investments invests in various stages of biotech and healthcare companies, including seed to Series A rounds, and corporate spinouts. They seek innovative companies within the healthcare and biotech sectors.

Investment Activity

Deals per year over the last 7 years

2012

2013

2014

2015

2016

2017

2018

Portfolio Companies

Selected investments from their portfolio of 224 companies

Tessera Therapeutics

Biotech · Series A, 2018

Active

Casma Therapeutics

Biotech · Series A, 2018

Active

iTeos Therapeutics

Biotech · Series A, 2017

Active

Poseida Therapeutics

Biotech · Series A, 2016

Active

ObsEva

Biotech · Series A, 2015

Active

Autolus Therapeutics

Biotech · Series A, 2015

Active

NextCure

Biotech · Series A, 2015

Active

Kura Oncology

Biotech · Series A, 2014

Active

Voyager Therapeutics

Biotech · Series A, 2014

Active

Spark Therapeutics

Biotech · Series A, 2013

Active

Inari Medical

Healthcare · Series A, 2013

Active

DBV Technologies

Biotech · Series A, 2012

Active

Notable Exits

CompanyTypeYearValue / Acquirer

Aurion BiotechAcquisition2024—

Inari MedicalIPO2020$1.4B

Spark TherapeuticsAcquisition2019$4.3B

MedDay PharmaceuticalsAcquisition2017—

ObsEvaIPO2017—

ActelionAcquisition2017$30B

GenSight BiologicsIPO2016—

ProQR TherapeuticsIPO2015—

GI DynamicsIPO2011—

Horizon TherapeuticsIPO2011$1.2B

Frequently Asked Questions

Sofinnova Investments focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Threshold

Menlo Park, United States · 841 deals

Lightspeed Venture Partners

Menlo Park, United States · 839 deals

Andreessen Horowitz

Menlo Park, United States · 826 deals

Khosla Ventures

Menlo Park, United States · 769 deals

Greylock

Menlo Park, United States · 720 deals

GGV Capital

Menlo Park, United States · 625 deals